US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist

2.050
-0.130-5.96%

Close Mar 10 16:00 ET

2.060
+0.010+0.49%

Post 20:01 ET

429.83MMarket Cap-1.32P/E (TTM)

Allogene Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Allogene Therapeutics Q4 2024 Estimates Date

Currency：USDMar 13, 2025

	Estimate	YoY
Revenue	12.00K	-42.86%
EPS	-0.33	+34.95%

Analyst Rating

Strong Buy

Feb 28, 2025

Allogene Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 5.000K	--
Mar 13, 2025	2024/Q4	-- / 12.000K	--
Nov 7, 2024	2024/Q3	0.000 / 10.670K	--
Aug 7, 2024	2024/Q2	0.000 / 1.777M	--
May 13, 2024	2024/Q1	22.000K / 10.430K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 5.000K--

Mar 13, 20252024/Q4-- / 12.000K--

Nov 7, 20242024/Q30.000 / 10.670K--

Aug 7, 20242024/Q20.000 / 1.777M--

May 13, 20242024/Q122.000K / 10.430K--

Unlock Free Earnings Estimates

Open Account

Allogene Therapeutics Earnings Reports

Allogene Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:20 ET

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update

Nov 7, 2024 16:10 ET

Allogene Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 16:14 ET

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update

Aug 7, 2024 16:07 ET